Home /

India Aims to Produce mRNA Covid-19 Vaccine This Year

September 29, 2021, 12:00 pm
India Aims to Produce mRNA Covid-19 Vaccine This Year
NEW DELHI—India is preparing to produce its own mRNA-based Covid-19 vaccine by the end of the year, in what would be a scientific breakthrough for the country’s growing pharmaceutical industry and help expand the range of global production hubs for the shots. A host of companies across the world are pushing to bring their own vaccines using the mRNA technology to market following the success of the Pfizer Inc. and Moderna Inc. shots. Indian firms, urged on in part by Prime Minister Narendra Modi, aim to be significant players in the new sector, with Gennova Pharmaceuticals Ltd. hoping to be the first.
Recommended news
Number of telephone spam in the US for the last 5 years has increased by 200%!
Everyone needs to be very careful and use the free phone number search
September 30, 2021, 12:00 pm
End of Covid-19 Jobs Program to Test U.K. Recovery
September 30, 2021, 9:22 am
Rohingya Civil-Rights Leader Mohib Ullah Killed in Bangladesh
September 30, 2021, 9:00 am
China’s Manufacturing Weakens, as Power Cuts Threaten More Damage
September 30, 2021, 3:00 am
North Korea Sees U.S. as Ongoing Threat, Kim Jong Un Says in Speech
September 30, 2021, 3:00 am
Prison Riot in Ecuador Leaves More Than 100 Dead, With Some Beheaded in Melee